ROM InWest Invests €1.5 million into AI and Computer Vision Company Kepler Vision Technologies

ROM InWest Invests

Kepler Vision Technologies, a software developer in the healthcare sector, has received an investment of €1.5 million from Dutch investment company ROM InWest. With the investment, the health-technology company will scale up the production of their Kepler Night Nurse. This smart sensor technology, applicable in elderly care among others, helps reduce the workload for healthcare professionals while simultaneously improving the quality of care.

Kepler Vision’s Night Nurse

Kepler Vision’s Night Nurse solution is a computer vision-based body language detection system. By combining AI and computer vision, Kepler Night Nurse is able to detect falls, patient discomfort and abnormal behaviour, notifying care staff so that they can respond immediately. The company has also recently added a new lying position detection feature that identifies the potential of pressure ulcers. This solution technology outperforms motion sensors, bed mats, and wearable monitoring systems by a factor of 1,000 in cutting down on false alarms, and the unnecessary strain they place on care staff.

International Distribution

The Night Nurse product has already been distributed internationally across 8 European countries through 26 different partners in care homes and hospitals. With the investment from ROM InWest, the company will look to widen its reach with plans of entering the UK and US market already in motion.

Harro Stokman, CEO of Kepler Vision Technologies says:

“The healthcare sector has been facing urgent staff shortages for years. This problem is only getting worse due to an aging population. A quarter of the current workforce will retire in the next five years, while the number of elderly people will continue to grow. Elderly care therefore needs more support than ever. Thanks to the investment from ROM InWest, we can scale up our Kepler Night Nurse production to help more healthcare professionals in their work. My goal is for our software to be accessible across the world, and with great support like this, we get closer to achieving this”.

Janet Nieboer, CEO of ROM InWest comments:

“We are proud to contribute to Kepler’s healthcare solution. The Kepler Night Nurse offers a smart and more reliable alternative to existing home automation systems. It contributes to good patient care and makes the work of healthcare professionals more efficient. Smart healthcare solutions like these are essential to maintain the quality and affordability of our healthcare.”

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”